Literature DB >> 12651152

Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene.

Thomas Asklund1, Ioulia B Appelskog, Ole Ammerpohl, Iver A Langmoen, M Sirac Dilber, Alar Aints, Tomas J Ekström, Per M Almqvist.   

Abstract

The ability of herpes simplex virus type 1 thymidine kinase (HSV-tk)-expressing cells incubated with ganciclovir (GCV) to induce cytotoxicity in neighboring HSV-tk-negative (bystander) cells has been well documented. Although it has been suggested that this bystander cell killing occurs via the transfer of phosphorylated GCV, the mechanism(s) of this bystander effect and the importance of gap junctions for the effect of prodrug/suicide gene therapy in primary human glioblastoma cells remains elusive. Surgical biopsies of malignant gliomas were used to establish explant primary cultures. Proliferating tumor cells were characterized immunohistochemically and found to express glial tumor markers including nestin, vimentin, glial fibrillary acidic protein (GFAP), S-100, and gap junction protein connexin 43 (Cx43). Western blot analysis revealed the presence of phosphorylated isoforms of Cx43 and Calcein/DiI fluorescent dye transfer showed evidence of efficient gap junction communication (GJC). In order to study the effect(s) of prodrug/suicide gene therapy in these cultures, human glioblastoma cell cultures were transfected with the HSVtk gene for transient or stable expression. Ganciclovir treatment of these cultures led to >90% of cells dead within 1 week. Eradication of cells could be inhibited by the addition of alpha-glycyrrhetinic acid (AGA), a GJC inhibitor. In parallel experiments, AGA decreased the immunodetection of phosphorylated Cx43 as analyzed by Western blot and inhibited fluorescent dye transfer. In conclusion, these observations are consistent with GJC as the mediator of the bystander effect in primary cultures of human glioblastoma cells by the transfer of phosphorylated GCV from HSVtk gene transfected cells to untransfected ones.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651152     DOI: 10.1016/s0014-4827(02)00052-6

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

Review 1.  Neural stem cell therapy for cancer.

Authors:  Juli Rodriguez Bagó; Kevin T Sheets; Shawn D Hingtgen
Journal:  Methods       Date:  2015-08-24       Impact factor: 3.608

Review 2.  The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system.

Authors:  Eliseo A Eugenin; Daniel Basilio; Juan C Sáez; Juan A Orellana; Cedric S Raine; Feliksas Bukauskas; Michael V L Bennett; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-23       Impact factor: 4.147

3.  Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Authors:  Donna N Douglas; Toshiyasu Kawahara; Banu Sis; David Bond; Karl P Fischer; D Lorne J Tyrrell; Jamie T Lewis; Norman M Kneteman
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

4.  Tumoricidal effect of human olfactory ensheathing cell mediated suicide gene therapy in human glioblastoma cells.

Authors:  Mansoureh Hashemi; Mahmoudreza Hadjighassem; Alireza Zali; Javad Hashemi
Journal:  Mol Biol Rep       Date:  2018-09-21       Impact factor: 2.316

5.  Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells.

Authors:  Edwin Bremer; Douwe Samplonius; Bart-Jan Kroesen; Linda van Genne; Lou de Leij; Wijnand Helfrich
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

6.  Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.

Authors:  Zi-Bo Li; Zhao-Jun Zeng; Qian Chen; Sai-Qun Luo; Wei-Xin Hu
Journal:  BMC Cancer       Date:  2006-03-16       Impact factor: 4.430

7.  Nestin expression in the cell lines derived from glioblastoma multiforme.

Authors:  Renata Veselska; Petr Kuglik; Pavel Cejpek; Hana Svachova; Jakub Neradil; Tomas Loja; Jirina Relichova
Journal:  BMC Cancer       Date:  2006-02-02       Impact factor: 4.430

Review 8.  Glioblastoma: molecular pathways, stem cells and therapeutic targets.

Authors:  Meena Jhanwar-Uniyal; Michael Labagnara; Marissa Friedman; Amanda Kwasnicki; Raj Murali
Journal:  Cancers (Basel)       Date:  2015-03-25       Impact factor: 6.639

9.  Vesicular Stomatitis Virus G Glycoprotein and ATRA Enhanced Bystander Killing of Chemoresistant Leukemic Cells by Herpes Simplex Virus Thymidine Kinase/Ganciclovir.

Authors:  Chenxi Hu; Zheng Chen; Wenjun Zhao; Lirong Wei; Yanwen Zheng; Chao He; Yan Zeng; Bin Yin
Journal:  Biomol Ther (Seoul)       Date:  2014-02       Impact factor: 4.634

10.  Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.

Authors:  Rosa A Castillo-Rodríguez; Martha L Arango-Rodríguez; Lourdes Escobedo; Daniel Hernandez-Baltazar; Anne Gompel; Patricia Forgez; Daniel Martínez-Fong
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.